Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
NCT05033106
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
36
Enrollment
OTHER_GOV
Sponsor class
Conditions
Retinopathy of Prematurity Both Eyes
Interventions
DRUG:
Bevacizumab, Ranibizumab
Sponsor
Zagazig University
Collaborators
[object Object]